trial

Facilitating Engagement in Evidence-Based Treatment for Early Psychosis

NCTId NCT04532034
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 12 (actual)
Sponsored by Temple University Collaborative on Community Inclusion
Primary completion 2023-03-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
12 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2020-09-01
Primary completion
2023-03-31
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
Peer-Delivered Decision Support Intervention

Sponsors

Temple University Collaborative on Community InclusionLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Elizabeth Shenkman, Ph.D.Principal Investigator

Sites

3 total
Broomall, United StatesDanville, United StatesPhiladelphia, United States

Facts & assertions

4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2023-03-31
Status
COMPLETED
relationships
The graph out of here
drug
Peer-Delivered Decision Support Intervention
drug
lead_sponsor
Temple University Collaborative on Community Inclusion
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Elizabeth Shenkman, Ph.D.
person